US 10696654
Therapeutic compounds
granted A61PA61P25/00A61P3/04
Quick answer
US patent 10696654 (Therapeutic compounds) held by C4X Discovery Limited expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4X Discovery Limited
- Grant date
- Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P25/00, A61P3/04